XingImaging

XingImaging is a clinical PET imaging service company based in China, specializing in the production of radiotracers and using positron emission tomography (PET) to evaluate and support the development of pathologic treatments for neurodegenerative diseases (including Alzheimer's disease and Parkinson's disease), oncology, and other conditions. XingImaging believes that quality is an integral part of the PET radiopharmaceuticals process and is essential for good business practices. Since it is impossible to analyze every chemical, biochemical, or physical entity within the radiopharmaceutical process, quality assurance measures are strategically applied to ensure the final product meets its intended purpose.